Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
about
Reversal of oral anticoagulationGuidance for the practical management of warfarin therapy in the treatment of venous thromboembolismAnticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor XaDental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.Efficacy and safety of the drugs used to reverse direct oral anticoagulants: a systematic review and meta-analysis.Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.Improving anticoagulation management in patients with atrial fibrillation.Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human bloodPharmacological Therapy in Stroke Prophylaxis - The New versus the Old AgentsHow to prevent, treat, and overcome current clinical challenges of VTE.Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.Acute stroke management in patients taking dabigatran.Treatment of dabigatran-associated bleeding: case report and review of the literature.Acute management of bleeding in patients on novel oral anticoagulants.Clinical management of rivaroxaban-treated patients.Reversal of target-specific oral anticoagulants.Oral anticoagulants in the management of venous thromboembolism.Newer clinically available antithrombotics and their antidotes.Balancing the risk of complications in foot and ankle surgical patients taking antithrombotic medication.Management of hemorrhage with the target-specific oral anticoagulants.Management of severe dabigatran-related hemorrhage: case report, considerations for management, and recommendations.Antithrombotic treatment at onset of stroke with atrial fibrillation, functional outcome, and fatality: a systematic review and meta-analysis.Perioperative Management of Antithrombotic Therapy in Common Otolaryngologic Surgical Procedures: State of the Art Review.Emergency Neurological Life Support: Pharmacotherapy.Beyond warfarin: The advent of new oral anticoagulants.Direct Oral Anticoagulants in Emergency Trauma Admissions.Perioperative management of patients on new oral anticoagulants.The Severity of Bleeding and Mortality in Trauma Patients Taking Dabigatran.Newer antithrombotic drugs[Rare complication of colonoscopy in a patient on anticoagulant: haemoperitoneum by rupture of a subcapsular hematoma of the spleen, clinical case].Pharmacotherapy Pearls for Emergency Neurological Life Support.Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors.Periprocedural Anticoagulant Management
P2860
Q26827835-F5F17D7E-1616-4D06-9FFD-F2783CF7D6A9Q28066527-F84B92D6-F605-46FC-9ED4-3CAA07010524Q34017336-9DF08D3D-89EB-4BA4-A735-6446B45E83A2Q34330708-5015EAF7-DB0E-411A-A71D-83E6C1A85D20Q36283736-AE241B2F-B04F-4CEA-BCF9-3366CD124CF4Q36321564-2003E28D-CA57-4608-AF77-73106ACE7B00Q36548878-8191FB4F-8729-4D66-9C9F-872A943A6CA3Q36801214-A26F8CCF-A5FA-4AD8-805A-E315BD1952CDQ37297475-F4C24F50-D73E-4E12-9036-2DC94BF1E0D4Q37495788-6EB02BBA-AF84-4E22-92B4-E1477E5056E1Q37903951-B54879D8-74AB-442A-A135-DEF39BC6F29CQ37924500-FB03F1B9-8DC2-43FA-B1E4-ED1C377ACBC4Q37999699-1E06BA71-29D0-47C6-8C2D-5FEAD4920944Q38005465-11084F5A-D939-4763-8E31-5F543E74F9F5Q38060565-C0CD6A48-86A2-43A4-BFA1-F94BC3429A09Q38065699-3389E8E1-7C84-4E4C-8D39-6345163CF10BQ38081946-6C3AA5A4-97CC-4C26-AA38-D66E3AEAF46CQ38105270-FBE98239-9096-449A-A615-DD37CA79C175Q38108205-6C85615D-46AF-486F-AB6D-4B12EFB343DAQ38220693-C1713185-F348-46C8-955F-90B08E67705EQ38233022-9EC596AD-4077-4F75-B67C-BBB39B4BA449Q38254250-A3CE50DA-B502-41E2-87EE-38376FE31AD3Q38266307-EA5E07BC-29CA-45C3-ADBE-3CF2B4B6593AQ38390896-3253F8F4-6527-4450-B59C-189C2109D84FQ38573932-1493E2C2-3B37-4D43-9D75-E7D348C5682CQ38599737-21692E8D-64D3-4936-B74F-97D098F757FBQ38692411-D47F0C8D-0657-4984-BAB1-4F6E176C76E3Q38961751-36E57D65-B522-4345-954F-9DD0D9B32576Q39201951-DFD01EFD-482E-4C0C-A3CD-CFA7EA42A537Q39641019-2380BFC7-988E-4AAF-B9BF-58C3A8642789Q41862291-0A06FD19-A6FF-45B6-BAA1-D9CB9F6E7274Q41982291-6A8E7024-204E-47E2-AC50-D797DBBFB56AQ45067456-66781B3A-4B50-4DC7-B03A-F061F7D3E821Q50956895-2D1D4995-B311-41EF-B161-5DE7A4CD74C2Q51035409-862D3767-E407-4A54-83A6-C57BEA5DC274Q55272081-A204ECD6-B4DB-4F12-8BAE-6DE1643C284EQ57907842-152A2BC9-8098-4517-A828-E095F32915D5
P2860
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
@ast
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
@en
type
label
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
@ast
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
@en
prefLabel
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
@ast
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
@en
P1476
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
@en
P2093
M A Crowther
P304
P356
10.1111/J.1538-7836.2009.03429.X
P478
P577
2009-07-01T00:00:00Z